IL-22 Receptor Synthetic Peptide, PEP-0110, from Invitrogen.
IL-22 Receptor Synthetic Peptide, PEP-0110, from Invitrogen.
A novel cytokine, designated IL-TIF for IL-10 related T cell-derived inducible factor and IL-22, was recently identified. The receptor for IL-22 (IL-22R, also termed CRF2-9 and IL-TIF-R1 chain) is a new member of the class II cytokine receptor family. IL-22R forms a complex with IL-10 receptor beta chain and mediates IL-22 signaling. IL-22 and its receptor activate JAK-STAT signaling pathway. IL22R is expressed in normal liver and kidney and their cell lines HepG2 and TK-10. A soluble form of IL-22 receptor, also termed IL-22 binding protein (IL-22BP) and IL-22 receptor-alpha 2 (IL-22RA2), was identified very recently. IL-22BP prevents binding of IL-22 to the functional cell surface IL-22R complex and neutralizes IL-22 activity. LPS induces IL-22 expression, which indicates the role of IL-22 in inflammatory response.
Conservation
Storage: -20°C.
Formulation
Concentration: 200 μg/mL.
Regulatory status
Research only (RUO).
Packaging
Packaging: 50 μg.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15206339 |
| Specifications |
| Gene ID (Enter) | 58985 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q8N6P7 |
| Common name | Human IL-22 Receptor alpha |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | IL22RA1 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
Origin and customs
| Manufacturer ref. | PEP-0110 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3824 99 96 00 |
|---|
A question or a specific configuration?
Contact us for a quote.